IL128095A - Formulation for the treatment and / or prevention of insanity - Google Patents

Formulation for the treatment and / or prevention of insanity

Info

Publication number
IL128095A
IL128095A IL12809597A IL12809597A IL128095A IL 128095 A IL128095 A IL 128095A IL 12809597 A IL12809597 A IL 12809597A IL 12809597 A IL12809597 A IL 12809597A IL 128095 A IL128095 A IL 128095A
Authority
IL
Israel
Prior art keywords
compound
composition according
dementia
pharmaceutically acceptable
use according
Prior art date
Application number
IL12809597A
Other languages
English (en)
Hebrew (he)
Other versions
IL128095A0 (en
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL128095A0 publication Critical patent/IL128095A0/xx
Publication of IL128095A publication Critical patent/IL128095A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12809597A 1996-07-25 1997-07-14 Formulation for the treatment and / or prevention of insanity IL128095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation
PCT/EP1997/003872 WO1998004258A1 (en) 1996-07-25 1997-07-14 Formulation for the treatment and/or prophylaxis of dementia

Publications (2)

Publication Number Publication Date
IL128095A0 IL128095A0 (en) 1999-11-30
IL128095A true IL128095A (en) 2002-07-25

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12809597A IL128095A (en) 1996-07-25 1997-07-14 Formulation for the treatment and / or prevention of insanity

Country Status (23)

Country Link
EP (1) EP0918521B1 (cs)
JP (1) JP2000515868A (cs)
KR (1) KR20000029523A (cs)
CN (1) CN1226163A (cs)
AR (1) AR007983A1 (cs)
AT (1) ATE224711T1 (cs)
BR (1) BR9710546A (cs)
CA (1) CA2261233A1 (cs)
CO (1) CO5031290A1 (cs)
CZ (1) CZ22799A3 (cs)
DE (1) DE69715878T2 (cs)
DK (1) DK0918521T3 (cs)
ES (1) ES2184121T3 (cs)
GB (1) GB9615628D0 (cs)
IL (1) IL128095A (cs)
NO (1) NO990283L (cs)
NZ (1) NZ333704A (cs)
PL (1) PL331283A1 (cs)
PT (1) PT918521E (cs)
TR (1) TR199900141T2 (cs)
TW (1) TW426514B (cs)
WO (1) WO1998004258A1 (cs)
ZA (1) ZA976592B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
KR100854213B1 (ko) * 2000-09-27 2008-08-26 디에스엠 아이피 어셋츠 비.브이. 콘쥬게이션 디엔의 카르보닐화 방법
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
KR102666727B1 (ko) 2017-12-29 2024-05-21 광저우 맥시노벨 파마수티컬스 씨오., 엘티디. 방향족 비닐 또는 방향족 에틸계 유도체, 그의 제조방법, 중간체, 약물조성물 및 용도
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
AU3768497A (en) 1998-02-20
ES2184121T3 (es) 2003-04-01
HK1021314A1 (en) 2000-06-09
KR20000029523A (ko) 2000-05-25
NZ333704A (en) 2000-06-23
DE69715878D1 (de) 2002-10-31
GB9615628D0 (en) 1996-09-04
ZA976592B (en) 1999-03-04
TR199900141T2 (xx) 1999-03-22
ATE224711T1 (de) 2002-10-15
CO5031290A1 (es) 2001-04-27
WO1998004258A1 (en) 1998-02-05
DE69715878T2 (de) 2003-05-22
PL331283A1 (en) 1999-07-05
EP0918521A1 (en) 1999-06-02
EP0918521B1 (en) 2002-09-25
BR9710546A (pt) 1999-08-17
NO990283D0 (no) 1999-01-22
CN1226163A (zh) 1999-08-18
CA2261233A1 (en) 1998-02-05
PT918521E (pt) 2003-02-28
AU721101B2 (en) 2000-06-22
IL128095A0 (en) 1999-11-30
CZ22799A3 (cs) 1999-06-16
NO990283L (no) 1999-03-19
TW426514B (en) 2001-03-21
AR007983A1 (es) 1999-11-24
JP2000515868A (ja) 2000-11-28
DK0918521T3 (da) 2003-02-03

Similar Documents

Publication Publication Date Title
JP3786684B2 (ja) オキシブチニンの経皮投与
US5747065A (en) Monoglyceride/lactate ester permeation enhancer for oxybutynin
US4910205A (en) Transdermal delivery of loratadine
US5900250A (en) Monoglyceride/lactate ester permeation enhancer for oxybutnin
JPH11506462A (ja) ロピニロールを含有してなる経皮製剤
AU720504B2 (en) Transdermal compositions containing levosimendan
US20020127271A1 (en) Formulation for the treatment and/or prophylaxis of dementia
EP0918521B1 (en) Formulation for the treatment and/or prophylaxis of dementia
KR100437672B1 (ko) 리스페리돈의방출조절형경피투여용제제
WO1997006788A1 (en) Transdermal administration of vorozole
AU721101C (en) Formulation for the treatment and/or prophylaxis of dementia
HK1021314B (en) Formulation for the treatment and/or prophylaxis of dementia
JPH09509676A (ja) ツメを使用する系統的な薬品配送システム
EP1216036B1 (en) Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines
HUP9903064A2 (hu) [R-(z)]-alfa-(metoxi-imino)-alfa-(1-aza-biciklo-[2.2.2.]okt-3-il)-acetonitrilt tartalmazó transzdermális gyógyszerkészítmény és eljárás előállítására
JP2002521324A (ja) フェノルドパムの経皮投与のための配合物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force